Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?

B Picatoste, I Cerro-Pardo, LM Blanco-Colio… - Frontiers in …, 2023 - frontiersin.org
Aortic aneurysms, including abdominal aortic aneurysms (AAAs), is the second most
prevalent aortic disease and represents an important cause of death worldwide. AAA is a …

[HTML][HTML] Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus

PI Li, HR Guo - World Journal of Diabetes, 2023 - ncbi.nlm.nih.gov
BACKGROUND Cardiovascular disease (CVD) is the leading cause of death globally, and
diabetes mellitus (DM) is a well-established risk factor. Among the risk factors for CVD, DM is …

Primary and secondary prevention of cardiovascular disease in diabetes with aspirin

O Schnell, M Erbach… - Diabetes and Vascular …, 2012 - journals.sagepub.com
Diabetes is associated with an increased cardiovascular risk. The role for aspirin in diabetes
is of high clinical interest. Guidelines recommend that primary prevention of cardiovascular …

Impact of unknown diabetes and prediabetes on clinical outcomes in “nondiabetic” Chinese patients after a primary coronary intervention

H Wang, Y Song, X Tang, J Xu, P Jiang, L Jiang… - Nutrition, Metabolism …, 2020 - Elsevier
Background and aim To explore the prevalence of unknown diabetes (DM) or prediabetes
(pre-DM) in “nondiabetic” patients and its association with 2-year clinical outcomes after …

Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an …

OS Costa, B O'Donnell, B Vardar… - Current Medical …, 2021 - Taylor & Francis
Background Patients with nonvalvular atrial fibrillation (NVAF) and type 2 diabetes are at risk
of kidney, limb, and ophthalmic complications. We evaluated the rate of these complications …

Increased intraplatelet ADMA level may promote platelet activation in diabetes mellitus

J Gawryś, J Wiśniewski… - Oxidative Medicine …, 2020 - Wiley Online Library
Background. Antiplatelet therapy has become a standard therapeutic approach in the
secondary prevention of cardiovascular system disorders of thrombotic origin. Patients with …

Acute effects of frequent light-intensity standing-based exercises that interrupt 8 hours of prolonged sitting on postprandial glucose in stroke survivors: A dose …

P Mackie, G Crowfoot, P Gyawali… - … of Physical Activity …, 2021 - journals.humankinetics.com
Background: Interrupting prolonged sitting can attenuate postprandial glucose responses in
overweight adults. The dose–response effect in stroke survivors is unknown. The authors …

Investigating the effect of some fluoroquinolones on C-reactive protein levels and ACh-Induced blood pressure reduction deviations after aging of diabetes in STZ …

HM Gharib, MY Abajy, A Omaren - Heliyon, 2020 - cell.com
The treatment of infections in diabetic patients by fluoroquinolone antibiotics is associated
with a reduced risk of coronary artery disease, and may improve endothelium-derived …

[PDF][PDF] Inlay tablet of atorvastatin calcium with sustained release metoprolol tartarate

SB Raj, E Mohanambal, KR Rani, SW Raja… - J. Pharm. Res, 2011 - Citeseer
The objective of this study was to design a dual retard technique of once daily Inlay tablet of
Atorvastatin calcium as Immediate Release (IR) formulation with Matrix tablet of Metoprolol …

Potentially inappropriate prescribing for adults with diabetes mellitus: a scoping review protocol

MB Ayalew, G Dieberg, F Quirk… - JBI Evidence Synthesis, 2020 - journals.lww.com
Objective: This scoping review aims to explore and map studies investigating potentially
inappropriate prescribing (PIP) for adults with diabetes mellitus. Introduction: Inappropriate …